Triple therapy aims to turn inoperable bowel cancer into a surgical target
Disease control
Not yet recruiting
This study tests whether combining chemotherapy (FOLFOX), a targeted drug (fruquintinib), and an immunotherapy (serplulimab) can shrink advanced colorectal cancer enough to allow surgery. About 42 adults with a specific type of colorectal cancer (pMMR/MSS) that cannot be removed …
Phase: PHASE4 • Sponsor: Ye Xu • Aim: Disease control
Last updated May 17, 2026 10:47 UTC